|
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs |
Dec 2020 |
Journal of Managed care and specialty pharmacy |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations |
Dec 2023 |
Journal of Blood Medicine |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis |
Jul 2024 |
Blood |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency |
Oct 2019 |
The Journal of Clinical Investigation |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Paroxysmal Nocturnal Hemoglobinuria |
Jan 2024 |
StatPearls |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease |
Nov 2020 |
British Journal of Haematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study |
Apr 2021 |
BMJ Supportive & Palliative Care |
Myelodysplastic Syndromes (MDS) |
|
Overview of the Management of Higher-Risk Myelodysplastic Syndromes |
May 2023 |
The Cancer Journal |
Myelodysplastic Syndromes (MDS) |
|
Outpatient transfusions for myelodysplastic syndromes |
Dec 2020 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates |
Feb 2025 |
Blood Advances |
Aplastic Anemia |
